Takeda Pharmaceutical Co. Ltd. · TSE:4502
Kim Julie So-Young received 73,234 Takeda Pharmaceutical Co. Ltd. shares as an award (Form 4)
Traded Jul 1, 2026 · Filed Jul 6, 2026
On Jul 1, 2026, Kim Julie So-Young (Director, President and CEO) received 73,234 Takeda Pharmaceutical Co. Ltd. shares as an award, leaving 22,800 shares. Filed Jul 6, 2026 (Form 4).
- Awarded
- 73,234 shares
- Holding after
- 22,800 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | American Depositary Shares | Award | 50,434 | 480,579 | Direct | |
| Jul 1, 2026 | Ordinary Shares | Award | 22,800 | 22,800 | Direct |
Source
Related
- Takeda Pharmaceutical Co. Ltd.
- Kim Julie So-Young
- Takeda Pharmaceutical Co. Ltd. shareholders
- Form 4 · Kim Julie So-Young · Aug 12, 2026
- Form 4 · Kim Julie So-Young · Apr 28, 2026
- Form 4 · Duprey Lauren Rusckowski · Sep 15, 2026
- Form 4 · Plump Andrew Stewart · Sep 3, 2026
- Form 4 · Plump Andrew Stewart · Aug 21, 2026
- Form 4 · Greenway Nicola Deidre Petal · Aug 19, 2026
- Form 4 · Shannon Elaine Mary · Aug 12, 2026